Exco InTouch Predicts Strong Growth in Mobile ePRO Release
Exco InTouch, a leading provider of digital patient engagement and data capture solutions for clinical research and healthcare providers, predicts ever increasing uptake of mobile electronic patient reported outcomes (ePRO) due to the multiple benefits that it brings to the market.
Electronic data collection has grown rapidly over the course of the last 10 years and has already emerged as a common asset in clinical research for the completion of Clinical Outcome Assessments (COA), including the outcomes captured directly from patients; patient reported outcomes (PRO). The global growth of mobile technology has provided a new and efficient method of accessing patients, creating an ideal platform for capturing ePRO assessments.
Mobile eCOA has brought a plethora of benefits to clinical studies. In addition to supporting diaries and questionnaires, native apps have proven a highly useful resource for facilitating the collection of objective data from medical devices, such as spirometers and glucometers, and wearable technology including activity trackers, alongside patient diaries. Data from these devices, transmitted directly into an app via Bluetooth, enables the collection of physiological data without the need for the patient to complete a site visit or the requirement to transcribe results manually.
Mobile eCOA can also boost patient engagement through the use of a simple, yet familiar interface supported by motivational messages, alerts, reminders and educational materials as appropriate for each study. Additionally, alerts can be raised to sites to highlight missed entries, enabling them to contact patients and discuss any difficulties or misunderstandings before the patient is lost to follow up.
Furthermore, mobile offers a safe and secure method of collecting patient data, protecting confidentiality in ePRO through the introduction of unique PINs created by the users. Both data transmission and offline storage is secured through data encryption. Data accessibility enables real-time access to PRO data by sites and sponsor teams through reports and metrics, providing comprehensive oversight to both individual and merged data.
Electronic data collection provides the benefit of being applicable through either the BYOD (Bring Your Own Device) approach or through provisioning devices. Adoption of the BYOD approach to collect eCOA data, which has been used in late phase post approval studies for some time, is now becoming increasingly used in Phase II & III clinical trials. Moreover, the use of apps simplifies device management, for example, by enabling remote deployment of interim study updates, without any need to recall patients and their devices back to sites.
As ePRO has become more embedded as a tool for clinical data capture, many PRO instruments that are widely accepted in paper formats have been adapted into ePRO versions. Since the manual, paper-based process for collecting PROs may not only be cost- and time-inefficient, but also unreliable, mobile devices will play an ever increasing role in the accumulation of patient endpoint data due to its ease of accessibility and cost- and time-efficiency.
Tim Davis, CEO and Founder of Exco InTouch, commented: “Mobile eCOA has proved to be highly beneficial and versatile for use in clinical trials, significantly improving the efficiency of studies and the quality of patient reported outcomes. It is set for further expansion and growth as the industry escalates the adoption of existing mobile PRO as the standard approach to self-reported clinical data.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance